Skip to content

Effect Of Apamargkshartail In Dushtavrana w.s.r Chronic Non Healing Wound

Effect of Apamarga Kshartail versus Placentrex gel in management of Dushta vrana w.s.r to chronic non healing wound-Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/12/060835
Enrollment
64
Registered
2023-12-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M959- Acquired deformity of musculoskeletal system, unspecified

Interventions

None listed

Sponsors

Mayur khedekar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient of age group between 10 year to 70 year. 2 Patients having clinical sign and symptoms of Dushta Vrana i.e. vedana, pooti gandha, strava, shotha etc. 3.Patient who can give written consent and regular follow up. 4. Wounds present for more than 4 weeks.

Exclusion criteria

Exclusion criteria: .Malignant ulcers 2. Syphilitic ulcers 3. Lepromatous ulcer 4. Tubercular ulcers 5. Patients having history of bleeding disorders 6. Anemia > 6 7. Burns 8. Diabetic Wound 9. HIV, HBsAg positive patients

Design outcomes

Primary

MeasureTime frame
To study the rate of healing of wound in. Apamarg Kshar Taila application groupTimepoint: 15 days

Secondary

MeasureTime frame
To study the complications & adverse effect of the drugs in both the groups.Timepoint: 15 days

Countries

India

Contacts

Public ContactDrJyoti shinde

Shri Ayurvedic Mahavidyalaya Nagpur

drjyoti.dalal@gmail.com9975830051

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026